Adult Acute Lymphocytic Leukemia: Future Research Directions
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 15 (1) , 207-211
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic LeukemiaJournal of Clinical Oncology, 2000
- Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaLeukemia & Lymphoma, 2000
- Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 1999
- Phase I study of liposomal daunorubicin in patients with acute leukemiaInvestigational New Drugs, 1999
- Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicinLeukemia, 1998
- Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patientsThe American Journal of Medicine, 1994